↓ Skip to main content

Levodopa for the treatment of restless legs syndrome

Overview of attention for article published in Cochrane database of systematic reviews, February 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
64 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Levodopa for the treatment of restless legs syndrome
Published in
Cochrane database of systematic reviews, February 2011
DOI 10.1002/14651858.cd005504.pub2
Pubmed ID
Authors

Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann, Magdolna Hornyak

Abstract

Levodopa plus dopamine decarboxylase inhibitor is a common treatment for restless legs syndrome (RLS).

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 23%
Student > Bachelor 10 16%
Researcher 7 11%
Student > Postgraduate 6 9%
Student > Ph. D. Student 5 8%
Other 8 13%
Unknown 13 20%
Readers by discipline Count As %
Medicine and Dentistry 28 44%
Psychology 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Nursing and Health Professions 3 5%
Social Sciences 3 5%
Other 6 9%
Unknown 16 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2019.
All research outputs
#4,350,349
of 14,322,164 outputs
Outputs from Cochrane database of systematic reviews
#7,342
of 10,950 outputs
Outputs of similar age
#81,736
of 282,041 outputs
Outputs of similar age from Cochrane database of systematic reviews
#179
of 246 outputs
Altmetric has tracked 14,322,164 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 10,950 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.8. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,041 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 246 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.